Kostyrko, Kaja
Boehringer Ingelheim (Austria)
3 papers on CoChatORCID 0000-0002-2842-4089
Most cited papers
- Verified
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
Han, K., Pierce, S. E., Li, A., Spees, K., Anderson, G. R., Seoane, J. A., Lo, Y.-H., Dubreuil, M., Olivas, M., Kamber, R. A., et al. (2020) · Nature
CRISPR and Genetic EngineeringCancer Genomics and Diagnostics
Cited by 311
- Verified
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance
Thatikonda, V., Lyu, H., Jurado, S., Kostyrko, K., Bristow, C. A., Albrecht, C., Alpar, D., Arnhof, H., Bergner, O., Bosch, K., et al. (2024) · Nature Cancer
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 76
- Verified
High-level transgene expression by homologous recombination-mediated gene transfer
Grandjean, M., Girod, P.-A., Calabrese, D., Kostyrko, K., Wicht, M., Yerly, F., Mazza, C., Beckmann, J. S., Martinet, D., & Mermod, N. (2011) · Nucleic Acids Research
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 53
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free